C-MER Medical Holdings Limited (the “Group”) announced a turnaround in its financial performance for the year ended 31 December 2025. The Group expects to record a profit attributable to equity holders of between HK$90.00 million and HK$110.00 million, reversing the HK$135.20 million loss recorded in 2024.

According to the company, revenue in 2025 slightly increased to approximately HK$1,947.00 million from HK$1,913.20 million in the previous year. Management attributed this turnaround to optimized service network strategies, including the closure of underperforming operations, and the absence of a material impairment loss on non-current assets, compared to the HK$197.70 million impairment loss recorded in 2024.

The company stated that these figures are based on preliminary management accounts and have not yet been audited or reviewed by its auditors or audit committee. The final annual results announcement is expected to be published by the end of March 2026. Investors are advised to exercise caution when dealing in the company’s shares.